Overview
GENB market data
Price History
GENB price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.59 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.56 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -637.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $11.00 – $18.18 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B.
Company News
Generate Biomedicines shares are trading lower after the company reported mixed Q2 financial results.Benzinga · Aug 6, 2026, 2:16 PM
Generate Biomedicines Q2 EPS $(0.52) Beats $(0.57) Estimate, Sales $6.314M Miss $6.625M EstimateBenzinga · Aug 6, 2026, 11:37 AM
Cathie Wood Likes That New Stock Smell: 3 IPO Stocks She Bought on MondayThe Motley Fool · Jul 7, 2026, 4:15 PM
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga · Jul 1, 2026, 12:05 PM
A Deep Dive Into Nvidia’s Latest Portfolio MovesInvesting.com · May 20, 2026, 1:15 PM
Generate Biomedicines shares are trading higher after a 13F filing revealed NVIDIA took a new 833,325-share stake.Benzinga · May 15, 2026, 8:26 PM
NVIDIA Corporation Increases Stake In CoreWeave To 47,213,353 Shares, Maintains Holdings In Intel Corporation (214,776,632 Shares), Nebius Group N.V. (1,190,476 Shares), Nokia Corporation (166,389,351 Shares), Synopsys (4,821,717 Shares), Takes New Stakes In Coherent Corp. (7,788,161 Shares) Generate Biomedicines (833,325 Shares).Benzinga · May 15, 2026, 8:24 PM
Nvidia Takes New Stake In Generate Biomedicines With 833,325 SharesBenzinga · May 15, 2026, 8:19 PM
Morgan Stanley Maintains Overweight on Generate Biomedicines, Raises Price Target to $22Benzinga · May 14, 2026, 5:15 PM